Podophyllotoxin sensitizes triple-negative breast cancer cells to CD47-targeted immunotherapy
{{output}}
Triple-negative breast cancer (TNBC) remains a highly aggressive malignancy with limited therapeutic options. Immunotherapeutic strategies are emerging as promising avenues to improve clinical outcomes in TNBC. Among these, CD47, a critical self-protective "d... ...
